Long-suffering victims of allergies such as asthma and hay fever might enjoy a surprise benefit, according to research led by the University of New South Wales (UNSW).
In a paper presented at an international symposium in Sydney, the researchers show that people with one of these atopic diseases are up to 25 percent less likely to get the most common type of Non-Hodgkin Lymphoma (NHL).
The InterLymph Symposium is co-hosted by the Leukaemia Foundation, the Cancer Institute NSW, UNSW and the National Centre in HIV Epidemiology and Clinical Research.